Several studies have shown that pregabalin could effectively inhibit NF-κB activation and cytokines secretion in the splenocytes, neuroblastoma, or glioma cells in vitro at a concentration of 1–25 μM [38, 39]. Here, NFKB1 is linked to central nervous system cancer.